Overexpression of Survivin has been reported in almost all human malignancies, including bladder cancer, lung cancer, breast cancer, stomach cancer, esophageal cancer, liver cancer, ovarian cancer and other cancer tissues [4–6]. This evidence concerns the gene BIRC5 and urinary bladder cancer.